JPH0456660B2 - - Google Patents
Info
- Publication number
- JPH0456660B2 JPH0456660B2 JP59132729A JP13272984A JPH0456660B2 JP H0456660 B2 JPH0456660 B2 JP H0456660B2 JP 59132729 A JP59132729 A JP 59132729A JP 13272984 A JP13272984 A JP 13272984A JP H0456660 B2 JPH0456660 B2 JP H0456660B2
- Authority
- JP
- Japan
- Prior art keywords
- droplets
- fluid
- capsule body
- solution
- functional substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002775 capsule Substances 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 31
- 239000012530 fluid Substances 0.000 claims description 29
- 150000004676 glycans Chemical class 0.000 claims description 18
- 229920001282 polysaccharide Polymers 0.000 claims description 18
- 239000005017 polysaccharide Substances 0.000 claims description 18
- 229920002101 Chitin Polymers 0.000 claims description 16
- 108010025899 gelatin film Proteins 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- 229920001661 Chitosan Polymers 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 229920000447 polyanionic polymer Polymers 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- -1 carboxylmethyl Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000850 deacetylating effect Effects 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ZUQUTHURQVDNKF-KEWYIRBNSA-N 1-[(3R,4R,5S,6R)-3-amino-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethanone Chemical compound CC(=O)C1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N ZUQUTHURQVDNKF-KEWYIRBNSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229920000869 Homopolysaccharide Polymers 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920002851 polycationic polymer Polymers 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59132729A JPS6111139A (ja) | 1984-06-27 | 1984-06-27 | 不安定な機能性物質を内包したカプセル体およびその製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59132729A JPS6111139A (ja) | 1984-06-27 | 1984-06-27 | 不安定な機能性物質を内包したカプセル体およびその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6111139A JPS6111139A (ja) | 1986-01-18 |
| JPH0456660B2 true JPH0456660B2 (enrdf_load_stackoverflow) | 1992-09-09 |
Family
ID=15088222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59132729A Granted JPS6111139A (ja) | 1984-06-27 | 1984-06-27 | 不安定な機能性物質を内包したカプセル体およびその製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6111139A (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62166891A (ja) * | 1986-01-20 | 1987-07-23 | Snow Brand Milk Prod Co Ltd | 細胞培養による有用物質の製造方法 |
| JP2594367B2 (ja) * | 1988-04-18 | 1997-03-26 | 新田ゼラチン株式会社 | 動物細胞大量培養法およびそれに用いる培養用支持基質の製法 |
| US6632457B1 (en) * | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
| JP2001000509A (ja) * | 1999-06-25 | 2001-01-09 | Kao Corp | カプセル粒子の製造方法 |
| CN109701443B (zh) * | 2017-10-25 | 2022-05-17 | 中国石油化工股份有限公司 | 滴球成型的方法 |
| CN109701442B (zh) * | 2017-10-25 | 2021-11-16 | 中国石油化工股份有限公司 | 滴球成型用滴球器和油氨柱成型装置 |
| CN111068579B (zh) * | 2018-10-22 | 2022-07-12 | 中国石油化工股份有限公司 | 滴球成型的方法 |
-
1984
- 1984-06-27 JP JP59132729A patent/JPS6111139A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6111139A (ja) | 1986-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5089272A (en) | Process for producing capsules having a permeability-controllable membrane | |
| US5902798A (en) | Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate | |
| US6165503A (en) | High strength capsules, process of preparing and using the same | |
| Gåserød et al. | Microcapsules of alginate–chitosan. II. A study of capsule stability and permeability | |
| JP2017133025A (ja) | ポリマーシェル | |
| WO1993012875A1 (en) | Method and apparatus for producing uniform polymeric spheres | |
| KR840003411A (ko) | 화학생물학적 약제의 캡슈울화 방법 및 그 조성물 | |
| CN103275962B (zh) | 一种微生物发酵前包被微胶囊的制备方法 | |
| CN111407722B (zh) | 一种银纳米粒子复合水凝胶、其制备方法及其应用 | |
| EP1063970A1 (de) | Mikrokapseln mit verzögertem release | |
| JPH0456660B2 (enrdf_load_stackoverflow) | ||
| CN106076214A (zh) | 一种具有核壳结构的海藻酸钙微球制备方法 | |
| CN102631680A (zh) | 一种利用氯化钠溶液处理海藻酸钙微球来调控微球载药量的方法 | |
| WO2011121019A2 (de) | Verfahren zur herstellung eines drug-delivery-systems auf der basis von polyelektrolytkomplexen | |
| JPH0453583B2 (enrdf_load_stackoverflow) | ||
| KR910003557B1 (ko) | 액체 서방성 약물 제형의 제조방법 | |
| Quigley et al. | Use of deacetylated gellan gum (Gelrite) for the production of sulphamethizole containing beads | |
| CN110698698A (zh) | 一种壳聚糖水凝胶的制备方法 | |
| CS268652B2 (en) | Method of microporous bodie production that occlude one or more active agents | |
| DE102011055861B4 (de) | Verfahren zur Herstellung monodisperser Pektin-Mikrogele unter Verwendung eines mikrofluidischen Systems | |
| JPS61125433A (ja) | マイクロカプセルの製造方法 | |
| JPS6139281B2 (enrdf_load_stackoverflow) | ||
| Zhang et al. | Modulation of electroosmotic flow in open tubular capillary electrochromatography by chitosan-assisted titanium oxide nanoparticles liquid phase deposition | |
| JPH0461882B2 (enrdf_load_stackoverflow) | ||
| JPH01245848A (ja) | 膜透過性制御可能なカプセル体の製造法 |